Showing results (321-330 of 861) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|January 11, 2025
Cell-mediated immunotherapy: A new frontier in preventing disease progression and treating drug-resistant cancerShimon SlavinMed (New York, N.Y.)|December 14, 2024
Searching for an oasis from the vasomotor symptoms of menopause: Could elinzanetant be the answer?Denise M Millstine, Juliana M KlingMed (New York, N.Y.)|August 20, 2024
Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetesJieli Lu, Ruixin Liu, Huahui Ren, et al.Med (New York, N.Y.)|August 10, 2024
Asciminib: the next-generation bullet for first-line treatment of chronic myeloid leukemiaChikashi Yoshida, Tomoiku TakakuMed (New York, N.Y.)|August 10, 2024
COX inhibition with anti-PD-1 in advanced dMMR colorectal cancer: Improving antigen presentation?Benoit Rousseau, Paul JohannetMed (New York, N.Y.)|August 10, 2024
Glucagon-like peptide receptor-1 receptor agonists: The emerging fourth pillar in type 2 diabetes and chronic kidney disease?James Ling, Elaine ChowMed (New York, N.Y.)|August 10, 2024
Therapy for HFpEF: A step forward brings new hope for people with obesity and diabetesLee-Ling Lim, Kamlesh KhuntiMed (New York, N.Y.)|July 16, 2024
Exceptional, naturally occurring HIV-1 control: Insight into a functional cureMaría Salgado, Stephen A Migueles, Xu G Yu, et al.Med (New York, N.Y.)|August 2, 2024
Association between situs inversus and maternal SARS-CoV-2 infection at gestational age 4-6 weeksZhenming Guo, Yingchun Luo, Yan Bi, et al.Med (New York, N.Y.)|August 16, 2024
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trialJeffrey A How, Minghao Dang, Sanghoon Lee, et al.Pageof 87